Study Design
This pilot parallel randomized clinical trial was conducted at a single center in Seattle, Washington, between March 1, 2019, and December 31, 2021, with follow-up for 90 days. Ethical and regulatory approval for the study was obtained from the Providence St Joseph Health Institutional Review Board. All participants provided written informed consent. We followed the Consolidated Standards of Reporting Trials (